Avanos Medical, Inc. (AVNS) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

18/25

Growth 5 Margin 2 Expansion 5 Platform 2 Financial 4

latest quarter score

Earnings Reports

18
Avanos (AVNS) Q4 2025: $30M Tariff Headwind Drives Supply Chain Pivot, Specialty Nutrition Outpaces Market
February 25, 2026
16
Avanos (AVNS) Q3 2025: Specialty Nutrition Surges 14.5% as Portfolio Reshaping Accelerates
November 05, 2025
16
Avanos (AVNS) Q2 2025: RFA Segment Grows 14%, Powering Portfolio Focus Post-HA Divestiture
August 05, 2025
15
Avanos (AVNS) Q2 2025: RFA Growth Hits 14% as HA Divestiture Refocuses Portfolio
August 05, 2025
Avanos Medical (AVNS) Q1 2025: $15M Tariff Hit Forces EPS Reset Despite 9% Nutrition Surge
July 06, 2025
Avanos Medical (AVNS) Q3 2024: Digestive Health Grows 6% as Transformation Offsets Pain Portfolio Setbacks
October 30, 2024
Avanos Medical (AVNS) Q2 2024: Digestive Health Grows 9%, Margin Expansion Signals Transformation Traction
July 31, 2024
AVNS Q1 2024: Digestive Health Delivers 9% Organic Growth, Margin Expansion Signals Transformation Traction
May 02, 2024
AVNS Q4 2023: HA Portfolio Down 35% as Transformation Targets Margin Expansion
February 20, 2024
Avanos (AVNS) Q3 2023: Digestive Health Up 10.5% as Pain Recovery Stabilizes
November 01, 2023
Avanos (AVNS) Q2 2023: Digestive Health Surges 17%, Pain Recovery Hinges on Supply Chain Relief
August 09, 2023
Avanos (AVNS) Q1 2023: Margin Rises 200bps as Cost Transformation Offsets Portfolio Headwinds
May 03, 2023
Avanos (AVNS) Q4 2022: $35M Product Exit Signals Portfolio Overhaul and Margin Ambition
February 21, 2023

Browse all companies